Raphael Franzini, Ph.D.

Addressing the current challenges faced by clinicians will require an interdisciplinary approach combining knowledge of diverse fields. My research group focuses on the interfaces of Chemistry, Biology and Medicine with the aim of developing novel types of therapeutic agents, imaging probes and diagnostic assays. Standard experimental techniques used to achieve this goal include synthetic organic chemistry, instrumental analysis, and basic molecular biology methods. One focus is on the development of reaction-based delivery of therapeutics to solid tumors with an emphasis on genitourinary malignancies. Furthermore, we develop DNA-encoded library solutions to find new pharmaceuticals for cancers and age-related chronic diseases.